News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,135 Results
Type
Article (858)
Company Profile (3)
Press Release (18274)
Multimedia
Podcasts (3)
Webinars (1)
Section
Business (5060)
Career Advice (3)
Deals (1077)
Drug Delivery (2)
Drug Development (2094)
Employer Resources (1)
FDA (339)
Job Trends (310)
News (8549)
Policy (720)
Tag
Academia (25)
Allergies (1)
Alliances (1562)
ALS (4)
Alzheimer's disease (13)
Antibody-drug conjugate (ADC) (1)
Approvals (357)
Artificial intelligence (24)
Autoimmune disease (1)
Automation (3)
Bankruptcy (8)
Best Places to Work (253)
Biosimilars (3)
Biotechnology (5)
Bladder cancer (8)
Brain cancer (2)
Breast cancer (6)
Cancer (134)
Cardiovascular disease (25)
Career advice (2)
CAR-T (6)
Cell therapy (24)
Clinical research (1783)
Collaboration (42)
Compensation (17)
Complete response letters (3)
COVID-19 (153)
C-suite (32)
Data (178)
Depression (3)
Diabetes (17)
Diagnostics (318)
Drug discovery (6)
Drug pricing (5)
Earnings (2198)
Editorial (1)
Employer resources (1)
Events (2993)
Executive appointments (35)
FDA (413)
Funding (31)
Gene editing (1)
Generative AI (2)
Gene therapy (8)
GLP-1 (71)
Government (70)
Guidances (9)
Healthcare (590)
Huntington's disease (3)
Immunology and inflammation (5)
Indications (3)
Infectious disease (164)
Inflammatory bowel disease (8)
Inflation Reduction Act (2)
Influenza (12)
Intellectual property (6)
IPO (461)
IRA (2)
Job creations (69)
Job search strategy (2)
JPM (4)
Labor market (2)
Layoffs (13)
Legal (178)
Liver cancer (1)
Lung cancer (34)
Lymphoma (15)
Machine learning (2)
Manufacturing (12)
MASH (6)
Medical device (540)
Medtech (540)
Mergers & acquisitions (659)
Metabolic disorders (35)
Multiple sclerosis (5)
Neurodegenerative disease (4)
Neuroscience (35)
NextGen: Class of 2026 (89)
Non-profit (20)
Now hiring (1)
Obesity (15)
Opinion (1)
Ovarian cancer (2)
Pain (3)
Pancreatic cancer (14)
Parkinson's disease (3)
Patents (7)
Patient recruitment (7)
Peanut (1)
People (1329)
Phase 1 (581)
Phase 2 (832)
Phase 3 (615)
Pipeline (154)
Policy (5)
Postmarket research (64)
Preclinical (236)
Press Release (1)
Prostate cancer (3)
Radiopharmaceuticals (5)
Rare diseases (5)
Real estate (114)
Recruiting (1)
Regulatory (594)
Reports (7)
Research institute (29)
Rett syndrome (1)
RSV (4)
Series A (8)
Series B (14)
Special edition (1)
Startups (94)
Supply chain (2)
The Weekly (3)
Vaccines (37)
Venture capital (4)
Weight loss (12)
Women's health (2)
Date
Today (1)
Last 7 days (24)
Last 30 days (57)
Last 365 days (813)
2026 (76)
2025 (833)
2024 (1023)
2023 (1051)
2022 (2145)
2021 (1793)
2020 (1274)
2019 (930)
2018 (813)
2017 (1031)
2016 (1072)
2015 (1206)
2014 (817)
2013 (550)
2012 (702)
2011 (634)
2010 (596)
Location
Africa (9)
Alabama (2)
Arizona (5)
Asia (543)
Australia (163)
California (167)
Canada (48)
China (5)
Colorado (2)
Connecticut (52)
Delaware (6)
Europe (7235)
Florida (51)
Georgia (2)
Illinois (10)
India (1)
Indiana (6)
Japan (5)
Maryland (66)
Massachusetts (224)
Michigan (3)
Minnesota (4)
Missouri (1)
Nebraska (1)
Nevada (24)
New Jersey (90)
New York (30)
North Carolina (10)
Northern California (79)
Pennsylvania (35)
Rhode Island (1)
South America (14)
South Carolina (1)
Southern California (60)
Texas (45)
United States (809)
Utah (5)
Virginia (2)
Washington State (4)
19,135 Results for "galapagos nv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cell therapy
Galapagos Exits Cell Therapy, Cuts 365 Employees
Galapagos at the start of the year had planned to split into two businesses, with one resulting entity focused on cell therapies. The biotech nixed these plans a few months later, instead choosing to put up for sale multiple cell therapy assets.
October 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
January 6, 2026
·
7 min read
Press Releases
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
August 6, 2025
·
6 min read
Mergers & acquisitions
JPM26: Galapagos’ New CEO Is Here To Finally Turn the Ship Around
Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of years of turmoil.
January 19, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
December 8, 2025
·
6 min read
Press Releases
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
·
3 min read
Press Releases
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast
January 20, 2026
·
1 min read
Press Releases
Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures
January 13, 2026
·
2 min read
Press Releases
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
October 31, 2025
·
5 min read
Press Releases
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
November 3, 2025
·
9 min read
1 of 1,914
Next
